GLENMEDE TRUST CO NA - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$246,000
-36.9%
4,406
-18.0%
0.00%0.0%
Q1 2022$390,000
-39.2%
5,375
-0.9%
0.00%
-33.3%
Q4 2021$641,000
-19.6%
5,426
-8.7%
0.00%
-25.0%
Q3 2021$797,000
-22.9%
5,944
-7.1%
0.00%
-20.0%
Q2 2021$1,034,000
+50.3%
6,396
-25.5%
0.01%
+25.0%
Q1 2021$688,000
+43.0%
8,585
-3.2%
0.00%
+33.3%
Q4 2020$481,000
+174.9%
8,8680.0%0.00%
+200.0%
Q3 2020$175,000
-29.7%
8,868
-25.8%
0.00%
-50.0%
Q2 2020$249,000
+128.4%
11,946
+58.3%
0.00%
Q1 2020$109,0000.0%7,5470.0%0.00%
Q4 2019$109,000
+153.5%
7,547
+125.5%
0.00%
Q3 2019$43,000
-4.4%
3,347
+21.7%
0.00%
Q2 2019$45,000
-2.2%
2,7500.0%0.00%
Q1 2019$46,000
+24.3%
2,7500.0%0.00%
Q4 2018$37,000
-56.5%
2,750
-11.3%
0.00%
Q2 2018$85,0003,1000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Discovery Value Fund 572,950$19,990,2265.79%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$39,952,2255.34%
MPM BioImpact LLC 455,238$15,883,2544.12%
ARK Investment Management 9,420,782$328,691,0842.85%
Atlas Venture Associates IX, LLC 10,000$348,9001.74%
Ghisallo Capital Management LLC 250,000$8,722,5001.55%
Nikko Asset Management Americas, Inc. 2,976,002$103,743,4301.49%
Prosight Management, LP 72,116$2,516,1271.37%
Rokos Capital Management LLP 826,063$28,391,7851.24%
Elmwood Wealth Management, Inc. 67,899$2,368,9961.18%
View complete list of INTELLIA THERAPEUTICS INC shareholders